BELRAPZO
NDC 42367-521, bendamustine hydrochloride, injection, from Eagle Pharmaceuticals, Inc.
- Product NDC
- 42367-521
- Status
- Listed
- Labeler
- Eagle Pharmaceuticals, Inc
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA205580
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42367-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BENDAMUSTINE HYDROCHLORIDE100 mg/4mL
Pharmacologic classes
Alkylating Activity [MoA]; Alkylating Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42367-521-25 | 42367052125 | 1 VIAL, MULTI-DOSE in 1 CARTON (42367-521-25) / 4 mL in 1 VIAL, MULTI-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9759a4ae-82ca-40cf-9c02-e1cadb21cbdcMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=42367-521
Use it
Look up 42367-521 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42367-521 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42367-521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.